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Ubiquitination Regulates PSD-95 Degradation
and AMPA Receptor Surface Expression
reserve insertion sites for AMPA receptors at the syn-
apse (Malinow and Malenka, 2002; Shi et al., 2001). Re-
cruitment of more slot proteins could lead to long-term
Marcie Colledge,1,4 Eric M. Snyder,3,4,5
Robert A. Crozier,3 Jacquelyn A. Soderling,1
Yetao Jin,2 Lorene K. Langeberg,1
potentiation (LTP) of synaptic transmission by increas-Hua Lu,2 Mark F. Bear, and John D. Scott1,*
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versely, long-term synaptic depression (LTD) could re-Vollum Institute
sult from a net loss of slot proteins and their complementOregon Health and Science University
of postsynaptic AMPA receptors. Thus, identifying slotPortland, Oregon 97239
proteins and their modes of regulation may provide valu-2 Department of Biochemistry and Molecular
able insight into the molecular basis of information stor-Biology
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a protein that escorts AMPA receptors to the synapse
(Chen et al., 2000; Schnell et al., 2002). Via this interac-
tion with stargazin, PSD-95 potentially could act as aSummary
docking site for AMPA receptors at the synapse. Consis-
tent with this notion, overexpression of PSD-95 in-PSD-95 is a major scaffolding protein of the postsyn-
creases the number of AMPA receptors at synapses (El-aptic density, tethering NMDA- and AMPA-type gluta-
Husseini et al., 2000; Schnell et al., 2002). Conversely,mate receptors to signaling proteins and the neuronal
removal of PSD-95 from the synapse by depalmitoyla-cytoskeleton. Here we show that PSD-95 is regulated
tion depletes synaptic AMPA receptors (El-Husseini etby the ubiquitin-proteasome pathway. PSD-95 inter-
al., 2000).acts with and is ubiquitinated by the E3 ligase Mdm2.
Recent evidence suggests that the ubiquitin-protea-In response to NMDA receptor activation, PSD-95 is
some pathway regulates many aspects of synapticubiquitinated and rapidly removed from synaptic sites
function (Hegde and DiAntonio, 2002; Murphey and Go-by proteasome-dependent degradation. Mutations
denschwege, 2002). For example, in C. elegans, ubiquiti-that block PSD-95 ubiquitination prevent NMDA-induced
nation of the glutamate receptor subunit GLR-1 regu-AMPA receptor endocytosis. Likewise, proteasome in-
lates the abundance of synaptic receptors (Burbea et
hibitors prevent NMDA-induced AMPA receptor inter-
al., 2002). At synapses of Aplysia and Drosophila, the
nalization and synaptically induced long-term depres-
ubiquitin-proteasome system regulates synaptic strength
sion. This is consistent with the notion that PSD-95 and growth (DiAntonio et al., 2001; Speese et al., 2003;
levels are an important determinant of AMPA receptor Zhao et al., 2003). At mammalian synapses, long-term
number at the synapse. These data suggest that ubi- alterations in synaptic activity can affect global changes
quitination of PSD-95 through an Mdm2-mediated in the composition of postsynaptic proteins, in part
pathway is critical in regulating AMPA receptor sur- through the ubiquitin-proteasome system (Ehlers, 2003).
face expression during synaptic plasticity. However, the identity of specific mammalian substrates
regulated by ubiquitination during synaptic plasticity re-
Introduction mains unknown.
Activation of NMDA receptors on hippocampal neu-
For synapses to store information, they must exhibit rons can cause a net loss of synaptic AMPA receptors
long-lasting changes after their modification by experi- and stable LTD (Carroll et al., 1999; Ehlers, 2000; Heynen
ence. At glutamatergic synapses in the brain, modifica- et al., 2000; Lee et al., 1998; Liao et al., 1999; Man et
tions can be triggered by activation of NMDA receptors al., 2000). These changes might be caused by reduced
and expressed as a change in the number of postsynap- synaptic expression of slot proteins. We therefore exam-
tic AMPA receptors (Malinow and Malenka, 2002). How- ined whether PSD-95 expression at the synapse is al-
ever, AMPA receptors are rapidly cycled through the tered by brief NMDA receptor activation. Here we report
postsynaptic membrane under basal conditions (Ehlers, that NMDA treatment leads to ubiquitination of PSD-95
and subsequent degradation by the 26S proteasome.2000; Lin et al., 2000; Lu¨scher et al., 1999). For transmis-
Like LTD and AMPA receptor internalization, this pro-sion to remain constant in the face of this turnover, it
cess requires calcium-dependent dephosphorylation ofhas been suggested that “slot proteins” must exist that
PKA substrates. Two lines of evidence suggest that reg-
ulation of PSD-95 levels by the ubiquitin-proteasome*Correspondence: scott@ohsu.edu
system is an important regulator of synaptic transmis-4 These authors contributed equally to this work.
sion and plasticity. First, we find that NMDA-induced5 Present address: The Laboratory for Cellular and Molecular
Neuroscience, Rockefeller University, New York, New York 10021. endocytosis of AMPA receptors is blocked by a mutation
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Figure 1. NMDA Treatment Causes Loss of
PSD-95 from Synapses and a Reduction in
Total Cellular PSD-95
(A) In the absence of NMDA treatment (upper
panels), PSD-95 (red) colocalizes with synap-
sin 1 (green) at synapses. In the composite,
colocalized synapsin and PSD-95 puncta ap-
pear yellow. Thirty minutes following NMDA
treatment (20 M, 3 min; bottom panels), syn-
aptic staining for PSD-95 was reduced, with-
out affecting synapsin immunoreactivity. Fol-
lowing NMDA stimulation, the overlay image
of PSD-95 and synapsin immunoreactivity is
dominated by green synapsin staining.
(B) Quantification revealed that, following
NMDA treatment, the intensity of PSD-95 was
reduced to 67%  4% of control levels (n 
250 synapses from ten cells in four cultures).
(C) NMDA treatment causes a loss of total
cellular PSD-95. (Panel 1) In control condi-
tions (DMSO), hippocampal neurons were
stimulated with NMDA (20 M, 3 min); cells
were lysed 30 or 60 min later, and total levels
of PSD-95 and transferrin receptor were ana-
lyzed. NMDA caused a rapid and long-lasting
loss of total PSD-95 (top panel); total levels
of transferrin receptor were unchanged (TfR;
bottom panel). (Panel 2) Reduction in PSD-
95 levels did not occur in calcium-free (Ca2-
free) media. (Panel 3) Treatment with the
PP2B antagonist ascomycin (Asco; 2 M)
prevented loss of PSD-95. (Panel 4) The ade-
nylyl cyclase activator forskolin (FSK; 50 M)
also prevented loss of PSD-95.
(D) NMDA stimulation causes a rapid reduc-
tion in relative PSD-95 levels (PSD-95/TfR
levels) that is maintained for at least 60 min
(n  5).
(E) Quantification of several experiments 60
min following NMDA treatment. NMDA-
induced reduction in PSD-95 levels was
blocked in calcium-free media (Ca2-free; n
4). PSD-95 loss did not occur in the presence
of the PP2B inhibitor ascomycin (Asco; n 
5) or the adenylyl cyclase activator forskolin
(FSK; n  5). For each condition, statistical
comparisons were made to the appropriate
vehicle control.
that prevents ubiquitination of PSD-95. Second, we PSD-95 extensively colocalized with synapsin (Figure
1A, upper panel). However, following NMDA stimulationshow that inhibiting the proteasome, which blocks PSD-
95 degradation, prevents NMDA-induced internalization (20 M, 3 min), the intensity of PSD-95 puncta was
of AMPA receptors and reduces synaptically induced reduced to 67%  4% of control levels (p  0.01; n 
LTD. These data suggest that the ubiquitin-proteasome 250 synapses from ten cells in four cultures; Figure 1A,
system regulates the molecular architecture of gluta- bottom panel; Figure 1B). These data suggest that
matergic synapses and plays a key role in synaptic plas- NMDA treatment causes a rapid loss of PSD-95 from
ticity in the mammalian brain. synaptic sites.
To further examine this phenomenon, we measured
Results the total cellular levels of PSD-95 following NMDA stimu-
lation. PSD-95 protein levels were assessed by Western
blot and quantified by densitometry. NMDA caused aActivation of NMDA Receptors Reduces
PSD-95 Protein Levels reduction in total PSD-95 levels by 15 min that was
maintained for at least 60 min (72%  5% of controlBrief exposure of cultured hippocampal neurons or acutely
prepared hippocampal slices to NMDA stimulates inter- levels, p  0.05, n  5; Figure 1C, upper panel 1 and
Figure 1D). In contrast, NMDA caused no decrease innalization of AMPA receptors and LTD of synaptic trans-
mission (Beattie et al., 2000; Ehlers, 2000; Lee et al., the levels of the transferrin receptor (Figure 1C, lower
panel 1), tubulin, or actin (data not shown).1998; Lu et al., 2001). To investigate the fate of PSD-95
following NMDA receptor activation, we labeled cultured Calcium influx through the NMDA receptor is known
to regulate many synaptic events, including LTD (Bearhippocampal neurons for the synaptic marker synapsin
1 (green) and PSD-95 (red; Figure 1A). In control cultures, and Malenka, 1994). To test whether it is required for
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the loss of cellular PSD-95, we repeated the experiments PSD-95. However, we are unable to establish at this
time whether this represents polyubiquitination orin calcium-free media. In the absence of external cal-
cium, NMDA-induced loss of PSD-95 was blocked monoubiquitination on multiple sites.
To test the specificity of this effect, we repeated these(105%  4% of control levels, p  0.3, n  5; Figure
1C, panel 2, and Figure 1E). experiments under identical conditions and immunopre-
cipitated GluR2-containing AMPA receptor complexesCalcium entry induces LTD by activation of the phos-
phatase PP2B (calcineurin; Mulkey et al., 1994). We hy- following NMDA treatment. We saw no evidence for
ubiquitination of GluR2 receptors following NMDA stim-pothesized that PP2B also may serve as a calcium sen-
sor in the downregulation of PSD-95 protein levels. To ulation (Figure 2C, upper panel), although control experi-
ments confirmed that GluR2 was efficiently immunopre-test this, we repeated experiments in the presence of
the potent and specific PP2B inhibitor ascomycin (Asco; cipitated (Figure 2C, bottom panel). These data suggest
that NMDA treatment induces the selective ubiquitina-2 M), an analog of FK-506 (Liu et al., 1991). Inhibition
of PP2B prevented the NMDA-induced loss of PSD-95 tion of PSD-95.
PEST sequences are known to regulate ubiquitination(97%  4%, p  0.4, n  5; Figure 1C, panel 3, and
Figure 1E). Together, these data suggest that PP2B is and rapid protein turnover (Rechsteiner and Rogers,
1996). The PEST-FIND program (www.at.embnet.org/required for the NMDA-induced loss of PSD-95.
PP2B can regulate synaptic strength through the de- embnet/tools/bio/PESTfind) predicts that PSD-95 con-
tains a PEST sequence at its N terminus (amino acidsphosphorylation of protein kinase A (PKA) substrates
(Beattie et al., 2000; Kameyama et al., 1998; Lee et al., 13–23 in rat PSD-95; Figure 2D). To determine if this
region in PSD-95 is important for its ubiquitination, we1998; Mulkey et al., 1994; Tavalin et al., 2002; Zeng
et al., 2001). We therefore hypothesized that the PKA generated a deletion mutant lacking this region—PSD-
95PEST. HEK293 cells were transfected with HA-taggedpathway may be involved in the loss of PSD-95. To test
this, we pretreated cultures with the adenylyl cyclase ubiquitin and PSD-95PEST or wild-type PSD-95. Ubi-
quitination of PSD-95PEST was dramatically reducedactivator forskolin (FSK; 50 M, 30 min) prior to applica-
tion of NMDA. Forskolin prevented the reduction of PSD- compared to wild-type PSD-95 (Figure 2E, top panel,
lanes 2 and 3), although equivalent amounts of both95 levels (110%  12% of control levels, p  0.2, n 
5; Figure 1C, panel 4, and Figure 1E). These data indicate proteins were immunoprecipitated (Figure 2E, bottom
panel). These data suggest that the PEST sequence inthat the cAMP/PKA pathway is involved in regulating
PSD-95 levels. PSD-95 is critical for its ubiquitination.
PSD-95 Is Associated with the Ubiquitin E3PSD-95 Is Ubiquitinated in Response to Activation
of NMDA Receptors Ligase Mdm2
Ubiquitination involves the sequential action of threeRecent work has shown that PDZ domain-containing
proteins are regulated by the ubiquitin pathway (Gardiol enzymes: the ubiquitin-activating enzyme (E1), a ubiqui-
tin-conjugating enzyme (E2), and a ubiquitin ligase (E3;et al., 1999; Glaunsinger et al., 2000; Lee et al., 2000b).
Ubiquitin is a 76 amino acid protein that is covalently Joazeiro and Hunter, 2000). Specificity is determined
by the E3 ligases, which specifically interact with theirattached to substrate proteins. Once tagged with ubiqui-
tin, substrate proteins are often targeted for rapid degra- protein substrates. As a further step toward understand-
ing a role for ubiquitination in regulating PSD-95, wedation by the 26S proteasome (Weissman, 2001). We
therefore hypothesized that NMDA receptor activation sought to identify its E3 ligase partner. Toward this end,
we immunoprecipitated four candidate ligases—Mdm2,may lead to a loss of PSD-95 via degradation by the
ubiquitin-proteasome pathway. To test this, we treated E6AP, Parkin, and Cbl—from synaptic plasma mem-
branes (Figure 3A). Each immune complex was screenedcultured hippocampal neurons with NMDA (20 M, 3
min), immunoprecipitated PSD-95 at different time points, for copurification of PSD-95 by immunoblot. PSD-95
was detected only in Mdm2 immunoprecipitates (Figureand immunoblotted the samples for ubiquitin. We ob-
served a rapid and transient increase in ubiquitination 3A, lane 6) but not in control IgG, E6AP, Parkin, or Cbl
complexes (Figure 3A, lanes 2–5). Control experimentsof PSD-95 that peaked approximately 10 min following
NMDA treatment (Figure 2A, top panel). As these experi- confirmed that each antibody did indeed immunoprecip-
itate its appropriate antigen (data not shown). In recipro-ments were performed under nondenaturing conditions,
it is possible that the ubiquitin-positive bands represent cal experiments, Mdm2 copurified with PSD-95 (Figure
3B, lane 3) but not with control IgG (Figure 3B, lane 2).a coprecipitating protein that associates with PSD-95.
However, the higher molecular weight ubiquitinated spe- In addition, neither E6AP, Parkin, nor Cbl copurified with
PSD-95 (data not shown). Collectively, these data pro-cies also were recognized specifically by PSD-95 anti-
bodies, suggesting that they are indeed ubiquitinated vide strong evidence that PSD-95 and Mdm2 interact
in synaptic membranes.forms of PSD-95 (Supplemental Figure S1 available at
http://www.neuron.org/cgi/content/full/40/3/595/DC1). To extend our biochemical data, we examined the
subcellular distribution of Mdm2 in cultured hippocam-Control experiments confirmed that equivalent amounts
of PSD-95 were immunoprecipitated in each condition pal neurons by immunocytochemistry (Figure 3C). Mdm2
(red) staining was predominantly punctate and coloca-(Figure 2A, bottom panel). Examination of total cell ex-
tracts showed a loss of total PSD-95 protein following lized with the synaptic marker synapsin 1 (green) at
many sites (Figure 3, upper panels). This was more evi-the NMDA treatment (Figure 2B), consistent with our
earlier results. These data indicate that NMDA receptor dent at higher magnification (Figure 3, lower panels).
Mdm2 was present at 64%  5% of synapsin punctaactivation leads to rapid and transient ubiquitination of
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Figure 2. NMDA Treatment Causes Ubiquiti-
nation of PSD-95 that Depends on a PEST
Motif
(A) NMDA stimulates ubiquitination of PSD-
95 in cultured hippocampal neurons. Hippo-
campal neurons were treated with NMDA (20
M, 3 min) and lysed at various times fol-
lowing treatment. PSD-95 was immunopre-
cipitated, and samples were immunoblotted
with ubiquitin antibodies. NMDA treatment
caused rapid ubiquitination of PSD-95 that
peaked at 10 min (upper panel, lane 3). Equiv-
alent amounts of PSD-95 were precipitated
in each condition (lower panel).
(B) NMDA treatment causes a loss of total
PSD-95 from neuron extracts by 30 min (up-
per panel; consistent with Figure 1C). NMDA
did not affect levels of the loading control
tubulin (lower panel).
(C) NMDA treatment does not stimulate ubi-
quitination of GluR2 AMPA receptors. The
same conditions that caused ubiquitination
of PSD-95 failed to stimulate ubiquitination
of GluR2 (upper panel), although GluR2 was
efficiently immunoprecipitated (lower panel).
(D) Cartoon of PSD-95 showing its modular
domain structure. PSD-95 contains three
PDZ domains, an SH3 domain, and a guanyl-
ate kinase (GK)-like region. At its N terminus,
PSD-95 contains a PEST motif (italicized).
PSD-95PEST lacks this sequence but re-
tains the palmitoylation sites (cysteines indi-
cated).
(E) Ubiquitination of PSD-95 requires the
PEST motif. HEK293 cells were transfected
with myc-tagged PSD-95 alone (lane 1), to-
gether with HA-tagged ubiquitin (lane 2), or
with a mutant form of PSD-95 lacking the
PEST sequence motif (PSD-95PEST) and HA-ubiquitin (lane 3). Wild-type PSD-95 was ubiquitinated (top panel; lane 2), whereas ubiquitination
of PSD-95PEST was dramatically reduced (top panel, lane 3). Reprobing the blot with antibodies against PSD-95 showed that equivalent
amounts of PSD-95 were precipitated in each case (bottom panel).
(n  250 synapses from four cultures). These data indi- to vector-transfected controls (Figure 4B, upper panel,
lane 1). Cotransfection of p14ARF increased PSD-95cate that Mdm2 is found at a majority of synapses in
hippocampal neurons. levels to 176%  23% of controls (Figure 4C; p  0.05,
n  3). As a control, we cotransfected GFP; p14ARF
had no effect on GFP levels (Figure 4B, bottom panel).PSD-95 Is Ubiquitinated by Mdm2
To test directly whether PSD-95 is a substrate for Mdm2, We next tested whether the PEST sequence in PSD-95
is important for regulation by Mdm2. In contrast to wild-we performed in vitro ubiquitination assays (Figure 4A).
GST-PSD-95 showed a laddering of higher molecular type PSD-95, PSD-95PEST levels were not increased
by cotransfection with p14ARF (Figure 4B, lanes 3 andweight ubiquitinated species when all components of
the ubiquitination machinery were present (Figure 4A, 4, and Figure 4C; p14ARF levels were 115%  17% of
vector-transfected controls, p  0.2, n  3), indicatingtop panel, lane 4). On shorter exposure, we confirmed
that equivalent amounts of GST-PSD-95 were used in that the PEST sequence is important for the Mdm2-
mediated degradation of PSD-95.each condition (Figure 4A, bottom panel). Parallel, posi-
tive control experiments confirmed that p53, a well-stud- As a corollary to these experiments, we asked whether
overexpression of Mdm2 reduces total levels of PSD-ied substrate for Mdm2, exhibited a similar laddering
of ubiquitinated species (data not shown). These data 95 (Figures 4D and 4E). We found that cotransfection
of Mdm2 reduced levels of PSD-95 to 56%  2% ofindicate that PSD-95 can indeed be ubiquitinated by
Mdm2. control levels (Figure 4D, lanes 1 and 2, and Figure 4E;
p 0.05, n 3). Overexpression of Mdm2 did not affectMdm2 activity can be specifically inhibited by the cel-
lular protein p14/19ARF (Sherr and Weber, 2000). If Mdm2 levels of PSD-95PEST (Figure 4D, lanes 3 and 4).
Finally, we examined ubiquitination of PSD-95 in cellsis important for degradation of PSD-95, then we would
predict that p14ARF would block this. We cotransfected from mice lacking Mdm2 (Montes de Oca Luna et al.,
1995). Mdm2/ mouse embryonic fibroblasts were trans-HEK293 cells (which endogenously express Mdm2) with
PSD-95 and p14ARF (Figure 4B). In the presence of fected with PSD-95, HA-tagged ubiquitin, and Mdm2
(Figure 4F). In the absence of Mdm2, PSD-95 was notp14ARF, we observed a significant increase in total
PSD-95 levels (Figure 4B, upper panel, lane 2), relative ubiquitinated (Figure 4F, top panel, lane 1). In contrast,
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Figure 3. PSD-95 Associates with Mdm2, a
Ubiquitin E3 Ligase
(A) PSD-95 copurifies with Mdm2. Extracts of
synaptic plasma membranes were subjected
to immunoprecipitation using antibodies
against several ubiquitin E3 ligases (lanes
2–6). PSD-95 copurified with Mdm2 (lane 6)
but not with control nonimmune IgG, E6AP,
Parkin, or Cbl. Extract (lane 1) represents 1%
of amount used in immunoprecipitation.
(B) Mdm2 copurifies with PSD-95. Synaptic
plasma membrane extracts were immuno-
precipitated with antibodies against PSD-95.
Mdm2 specifically copurified in PSD-95 pre-
cipitates (lane 3) but not in control IgG precip-
itates (lane 2). Extract (lane 1) represents 10%
of total used in immunoprecipitation.
(C) Mdm2 is localized at synapses. (Upper
panel) Cultured hippocampal neurons were
labeled with anti-synapsin 1 antibodies (green)
to mark synaptic sites and Mdm2 antibodies
(red). Overlay demonstrates that Mdm2 im-
munoreactivity is present at a majority of syn-
apses. (Lower panel) Higher-magnification
view (corresponding to region marked by
boxes in upper panel) shows that 64%  5%
(n  250 synapses from four cultures) of sy-
napsin 1-positive sites are immunoreactive
for Mdm2. Examples of synapses positive for
both synapsin 1 and Mdm2 are indicated
with arrows.
PSD-95 was ubiquitinated in rescue experiments in (Schnell et al., 2002), then treatments that inhibit protea-
which Mdm2 was transfected back into these cells (Fig- somal degradation of PSD-95 also should interfere with
ure 4F, top panel, lane 2). In comparison, ubiquitination NMDA-induced loss of surface AMPA receptors. To test
of PSD-95PEST was greatly reduced (Figure 4F, lanes this, we measured surface expression of AMPA recep-
3 and 4), although similar amounts of PSD-95 and PSD- tors using a biotinylation assay (Snyder et al., 2001). We
95PEST were immunoprecipitated (Figure 4F, bottom found that NMDA treatment (20 M, 3 min) caused a
panel). Collectively, the data in Figure 4 strongly support long-lasting loss of surface GluR1 (Figures 5D and 5F;
the notion that Mdm2 is required for ubiquitination and 60%  5% of control levels at 60 min, p  0.05; n  6).
degradation of PSD-95 and that the PEST sequence is There was no change in surface levels of transferrin
critical in this process. receptors (Figure 5F). In the presence of MG132, how-
ever, the NMDA-induced loss of surface GluR1 was
The Proteasome Regulates PSD-95 Levels completely blocked (Figures 5E and 5G; 104%  5% of
Following ubiquitination, substrate proteins are often control levels at 60 min, p  0.4, n  7). These data
targeted to the 26S proteasome for degradation (Pickart, indicate that inhibiting proteasome activity, which blocks
2000). To test whether the proteasome is involved in degradation of PSD-95, prevents the loss of surface
the NMDA-induced degradation of PSD-95, we treated AMPA receptors following NMDA receptor activation.
primary hippocampal neuron cultures with the cell-per- We next used immunocytochemistry to visualize
meable proteasomal inhibitor MG132 (50 M, 1 hr), prior changes in surface-expressed, synaptic AMPA recep-
to NMDA stimulation (20 M, 3 min). As before, NMDA tors (Figures 5H–5K). NMDA (20 M, 3 min) caused a
alone induced a loss of total PSD-95 protein (Figures loss of synaptic GluR2 (Figures 5H, 5I, and 5L; intensity
5A and 5C; 60%  15% of DMSO control, p  0.05, n  of GluR2 puncta was 55%  11% of controls; p  0.05,
5). In contrast, MG132 completely blocked this effect n  10). In contrast, pretreatment with MG132 (50 M,
(Figures 5B and 5C; 110%  14% of MG132 alone, p  30 min) significantly blocked the NMDA-induced loss of
0.2, n 5). The structurally distinct proteasomal inhibitor surface GluR2 (Figures 5K and 5L; 82% 16% of DMSO,
lactacystin also blocked the NMDA-induced degrada- p  0.05, n  10 cells). These data further support a
tion of PSD-95 (Supplemental Figure S2 at http://www. role for the proteasome in regulating AMPA receptor
neuron.org/cgi/content/full/40/3/595/DC1). These data surface expression.
suggest that, following NMDA stimulation, ubiquitinated
PSD-95 is degraded by the 26S proteasome.
Ubiquitination of PSD-95 Regulates Endocytosis
of AMPA ReceptorsThe Proteasome Regulates Surface
To test directly if ubiquitination of PSD-95 regulatesAMPA Receptors
AMPA receptor internalization, we transfected culturedIf PSD-95 determines the capacity of the synaptic mem-
brane for AMPA receptors, as has been hypothesized hippocampal neurons with PSD-95PEST, which is de-
Neuron
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Figure 4. Mdm2 Ubiquitinates PSD-95 and Regulates Its Expression Levels
(A) Mdm2 directly ubiquitinates PSD-95. GST-PSD-95 was incubated with ubiquitin (Ub), E1 (UBA1), E2 (UBC5), and Mdm2 (E3; lanes 3–7).
Ubiquitination was detected using PSD-95 antibodies. GST-PSD-95 showed a laddering of higher molecular weight ubiquitinated species
when the full complement of the ubiquitination machinery was present (upper panel; lane 4). Equal amounts of GST-PSD-95 were used in
each reaction (lower panel).
(B) p14ARF stabilizes cellular levels of PSD-95. HEK293 cells were transfected with either myc-tagged PSD-95 (lanes 1 and 2) or PSD-95PEST
(lanes 3 and 4) and GFP, in the absence or presence of myc-tagged p14ARF, a cellular inhibitor of Mdm2 activity. In the presence of p14ARF,
levels of PSD-95 protein in total cellular extracts were increased (upper panel; compare lanes 1 and 2). p14ARF did not affect levels of PSD-
95PEST (lane 4) nor of cotransfected GFP (bottom panel).
(C) Quantification of p14ARF effect. p14ARF increases the levels of wild-type PSD-95 to 176%  23% of control levels (p  0.05, n  3) but
does not alter levels of PSD-95PEST (115%  17% of controls, p  0.2, n  3).
(D) Mdm2 reduces total PSD-95 levels. HEK293 or H1299 cells were transfected with myc-tagged PSD-95 (lanes 1 and 2) or PSD-95PEST
(lanes 3 and 4) in the absence and presence of Mdm2. In the presence of Mdm2, levels of PSD-95 protein in total cell extracts were reduced
(upper panel, lane 2). Expression of Mdm2 had no effect on levels of PSD-95PEST (upper panel, lane 4). Equivalent amounts of extracts
were loaded in each condition (tubulin; bottom panel).
(E) Quantification of Mdm2 effect. Expression of Mdm2 decreases levels of PSD-95 to 56%  9% of control levels (p  0.05, n  3).
(F) In the absence of Mdm2, PSD-95 is not ubiquitinated. Mouse embryonic fibroblasts lacking Mdm2 (Mdm2/), were transfected with myc-
tagged PSD-95 (lanes 1 and 2) or PSD-95PEST (lanes 3 and 4) and HA-ubiquitin, with or without Mdm2. Cells were lysed, and PSD-95 was
immunoprecipitated. Only when Mdm2 was reintroduced into the cells was PSD-95 ubiquitinated (upper panel, lane 2). Mdm2-mediated
ubiquitination of PSD-95PEST was greatly reduced (upper panel, lane 4). Equivalent amounts of PSD-95 were immunoprecipitated in all
conditions (bottom panel).
fective in its ability to be ubiquitinated. An antibody we hypothesized, transfection of PSD-95PEST (middle
panels) blocked both the NMDA-induced loss of surfacefeeding protocol was used to measure AMPA receptor
endocytosis following NMDA treatment (Figure 6; Ehlers, AMPA receptors (Figures 6A and 6B; red, middle panels;
Figure 6C; control: 3.6  0.34 puncta/10 m; NMDA:2000; Lin et al., 2000). Using this method, we were able
to monitor both surface and internal pools of AMPA 3.25  0.2 puncta/10 m, p  0.09, n  15) and the
increase in internalized receptors (Figure 6A, green; Fig-receptors. In control, untransfected cells (left panels),
NMDA treatment () caused internalization of GluR2. ure 6D; control: 0.33 0.2 puncta/10 m; NMDA: 0.68
0.17 puncta/10 m; p  0.15, n  15). These data indi-This was measured as a loss in the density of surface
GluR2 puncta (Figures 6A and 6B; red, left panels; Figure cate that overexpression of PSD-95PEST reduces
NMDA-stimulated AMPA receptor endocytosis, sug-6C; control: 2.6  0.6 puncta/10 m; NMDA: 1.9  0.3
puncta/10 m; p  0.02, n  16) and an increase in the gesting that ubiquitination of PSD-95 is necessary for
efficient internalization of AMPA receptors. These re-density of internal GluR2 puncta (Figures 6A and 6B;
green; Figure 6D; control: 0.44  0.1 puncta/10 m; sults are more clearly illustrated in higher-magnification
views of the neuronal dendrites (Figure 6B).NMDA: 2.1  0.15 puncta/10 m, p  0.01, n  16). As
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Figure 5. The Proteasome Regulates PSD-
95 Degradation and Surface AMPA Recep-
tor Expression
(A) Under control conditions, NMDA (20 M,
3 min) causes a loss of total PSD-95 protein
in hippocampal neurons ().
(B) MG132 prevents NMDA-induced degra-
dation of PSD-95. Cultures were treated with
MG132 (50 M, 1 hr) prior to NMDA stimula-
tion. Inhibiting the proteasome with MG132
blocks this NMDA-induced degradation of
PSD-95 (). The proteasomal inhibitor lacta-
cystin also blocked PSD-95 degradation
(data not shown).
(C) Quantification of PSD-95 levels. NMDA
causes degradation of PSD-95 (60%  15%
of controls; n 5). MG132 prevents this effect
(110%  14% of MG132 alone; n  5).
(D) NMDA causes loss of surface AMPA re-
ceptors. Cultures were treated with DMSO (1
hr) and then stimulated with NMDA (20 M,
3 min). One hour following NMDA treatment,
the cultures were biotinylated, and surface
proteins were precipitated with neutravidin
sepharose. NMDA treatment caused a loss
of surface GluR1 ().
(E) MG132 prevents NMDA-induced loss of
surface AMPA receptors. Cultures were incu-
bated in MG132 (50 M, 1 hr) prior to NMDA
(20 M, 3 min) treatment, and surface recep-
tors were isolated 1 hr later. NMDA-induced loss of surface GluR1 was blocked by MG132 (; right lane).
(F) Quantification reveals that NMDA reduces surface GluR1 by 30% within 15 min and that this effect lasts at least 1 hr. There was no change
in levels of transferrin receptor (TfR) over this time.
(G) In MG132, NMDA-induced changes in surface GluR1 are blocked. There was no change in levels of transferrin receptor (TfR).
(H–K) Hippocampal cultures were pretreated with MG132 (50 M, 30 min) prior to NMDA stimulation (20 M, 3 min). Fifteen minutes later,
surface GluR2 receptors were labeled. NMDA caused a reduction in surface GluR2 staining. MG132 blocked this effect.
(L) Following NMDA treatment, the intensity of GluR2 puncta was 55%  11% of controls (n  10 cells from four cultures). MG132 largely
blocked the NMDA-induced loss of surface GluR2 (82%  16% of controls; n  10 cells from four cultures).
We also examined neurons transfected with wild-type or lactacystin. LTD was reliably induced in vehicle con-
trol cells using a pairing protocol (Figures 7A and 7B;PSD-95 (Figure 6A, right panels). NMDA-induced endocy-
tosis of AMPA receptors was blunted in PSD-95-express- 52%  10% reduction relative to baseline responses). In
contrast, inhibition of proteasome activity by MG132ing neurons compared to control neurons; however, en-
docytosis was greater than in PSD-95PEST neurons. In significantly attenuated LTD (Figures 7A and 7B; 78%
5% of baseline responses, p  0.03). MG132 itself hadPSD-95-expressing neurons, NMDA treatment caused a
reduction in surface GluR2 puncta density (Figure 6C; no effect on basal synaptic transmission (data not shown).
To confirm a role for the proteasome in this process, wecontrol: 3.5  0.26 puncta/10 m; NMDA: 2.6  0.3
puncta/10 m, p  0.05, n  16) and an increase in repeated the experiments with the structurally distinct
proteasome inhibitor lactacystin. Lactacystin also blockedinternal GluR2 puncta density (Figure 6D; control: 0.36
0.37 puncta/10 m; NMDA: 1.44  0.16 puncta/10 m, LTD (Figures 7C and 7D; 95%  14% of baseline re-
sponses, p  0.05). Together these data suggest a rolep  0.05, n  16). Higher-magnification views (Figure
6B, right) illustrate these effects. These results suggest for the proteasome in the regulation of synaptic de-
pression.that overexpression of PSD-95 can partially reduce the
effect of NMDA on AMPA receptor endocytosis, consis-
tent with a role for PSD-95 in stabilizing surface AMPA Discussion
receptors. Together, these data indicate that PSD-95
plays a direct role in regulating AMPA receptor traffick- Although the postsynaptic density (PSD) appears rigid
ing and that ubiquitination of PSD-95 is required for and insoluble, it is a dynamic structure and the site of
AMPA receptor endocytosis. continual plasticity. We show here that the levels of
PSD-95, a major organizer of the PSD, are regulated by
ubiquitination. This process is signaled through NMDAThe Proteasome Regulates Hippocampal LTD
Finally, we tested whether proteasomal degradation of receptor activation, which induces ubiquitination of
PSD-95 and its removal from synaptic sites by degrada-PSD-95 might be an underlying mechanism for the activ-
ity-dependent removal of glutamate receptors during tion. Loss of PSD-95 presumably untethers AMPA re-
ceptors from the postsynaptic membrane, allowing forLTD. We isolated hippocampal slices from young rats
and performed whole-cell voltage-clamp recordings of their subsequent removal from synaptic sites by endo-
cytosis. We propose that through rapid and dynamicCA1 neurons intracellularly perfused with vehicle, MG132,
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Figure 6. Ubiquitination of PSD-95 Regulates Endocytosis of AMPA Receptors
(A) (Top row) An antibody feeding technique was used to visualize endocytosed GluR2 in untransfected neurons (blue; left panels), neurons
transfected with myc-PSD-95PEST (blue; middle panels), or myc-tagged PSD-95 (blue; right panels). (Middle row) In untransfected neurons,
NMDA treatment causes a loss of surface GluR2 staining (red; ; left panels). NMDA-induced loss of surface GluR2 is largely blocked in PSD-
95PEST-expressing neurons (red; middle panels) and blunted in neurons expressing wild-type PSD-95 (red; right panels). (Bottom row) In
untransfected neurons (; left panels), there is scant intracellular GluR2 staining (green). NMDA treatment (20 M, 3 min) causes internalization
of GluR2 (green; ; left panels). NMDA-induced GluR2 endocytosis was blocked in neurons expressing PSD-95PEST (green; middle panels).
NMDA-induced endocytosis of GluR2 was partially inhibited in neurons expressing wild-type PSD-95 (green; right panels). Background levels
of myc antigen are faintly detected in the control neurons.
(B) Higher-magnification view of representative dendritic regions shows that in untransfected neurons (left column), NMDA treatment causes
a loss of surface GluR2 (red) and a concomitant increase in intracellular GluR2 (green). In contrast, in neurons expressing PSD-95PEST
(middle column), the NMDA-induced loss of surface GluR2 (red) and increase in intracellular GluR2 (green) is largely attenuated. Both NMDA
effects are blunted in neurons expressing wild-type PSD-95 (right columns).
(C) Quantification of the density of surface GluR2 puncta revealed untransfected, untreated control neurons had 2.6  0.6 GluR2 puncta/10 m
(n  16). Following NMDA treatment, untransfected neurons exhibited 1.9  0.3 puncta per 10 m (p  0.02 versus control, n  16). In neurons
expressing PSD-95PEST, GluR2 puncta density was 3.6 0.4/10 m (n  15). NMDA treatment did not cause a significant decrease in density of
surface GluR2 puncta (3.25  0.2/10 m, p  0.09, n  15). Neurons expressing wild-type PSD-95 had 3.5  0.26 puncta/10 m (n  16). NMDA
treatment reduced GluR2 puncta density to 2.6 0.3/10m (p 0.05, n 16). Quanitatnion of data were performed using a double blind protocol.
(D) In untransfected neurons, NMDA treatment increased the density of internalized GluR2 puncta from 0.44  0.1 puncta/10 m to 2.1  0.15
puncta/10 m within 30 min (n 16, p  0.01). This NMDA-induced increase in internal GluR2 was blocked by transfection with PSD-95PEST
(control: internal GluR2 puncta was 0.33  0.2 puncta/10 m; n  15; NMDA: internal GluR2 density was 0.68  0.17/10 m; n  15, p  0.15).
In neurons expressing wild-type PSD-95, NMDA had a reduced effect compared to controls (0.36  0.37 puncta/10 m in untreated cells
versus 1.44  0.16 puncta/10 m in NMDA treated cells; n  16, p  0.05). Quantitation of data were performed using a double blind protocol.
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Figure 7. Inhibition of the Proteasome Reduces the Magnitude of Hippocampal LTD
(A and C) Sample EPSCs from a hippocampal slice illustrate the effect of MG132 (A) and lactacystin (C) on pairing-induced synaptic depression.
CA1 pyramidal neurons were voltage-clamped at 65 mV. Following the pairing protocol, EPSCs were reduced by 50% in DMSO vehicle
control recordings. Inhibition of proteasome activity by MG132 (1 M) and lactacystin (10 M) significantly attenuated LTD. Sweeps are the
average of consecutive responses taken 5 min prior to pairing onset (1) and 25–30 min following completion of the pairing protocol (2). All
recordings were performed in the presence of the GABAA antagonist picrotoxin (50 M). Scale bars, 50 pA, 30 ms (A); 25pA, 25 ms (C).
(B and D) Overlay of grouped data time courses demonstrates that MG132 (B) and lactacystin (D) attenuate LTD magnitude. Following 15 min
of stable baseline recording, LTD was induced at time zero by a pairing protocol (black bar) and assessed 25–30 min after pairing. Proteasome
inhibition by MG132 (; n  6) or lactacystin (; n  7) significantly reduced the magnitude of LTD compared to DMSO control (; n  6, 3
for panels [B] and [D], respectively). Plotted on the leftward y axis is EPSC amplitude normalized to a 15 min baseline period. Each symbol
represents data averaged into 2 min bins.
modification of a major PSD component, the ubiquitin- anchoring protein AKAP79/150 (Colledge et al., 2000).
In this way, the enzymes are optimally positioned toproteasome pathway is critically involved in regulating
synaptic strength and plasticity. The ideas are presented regulate AMPA receptor phosphorylation and activity
(Colledge et al., 2000; Oliveria et al., 2003; Rosenmundin a model (Figure 8).
Our pharmacological studies suggest that activation et al., 1994; Tavalin et al., 2002; M.L. Dell’Acqua, L.L.
Gomez, S. Alam, A. Bishop, and J.D. Scott, 2001, Soc.of the calcium-sensitive phosphatase PP2B may play
a role in the ubiquitination/degradation of PSD-95 by Neurosci., abstract). Future studies are planned to ex-
amine a potential role for the AKAP79/150 signalingMdm2. During LTD, activation of PP2B initiates a signal-
ing cascade that results in the dephosphorylation of complex in coupling calcium signals to activation of a
Mdm2/ubiquitin pathway.synaptic PKA substrates (Beattie et al., 2000; Ehlers,
2000; Kameyama et al., 1998; Lee et al., 2000a; Lee et Ubiquitination regulates synaptic strength, plasticity
and structure in invertebrates and mammals (Burbea etal., 1998). The GluR1 subunit of the AMPA receptor is
one likely candidate substrate (Banke et al., 2000; Lee al., 2002; Chain et al., 1999; DiAntonio et al., 2001; Ehlers,
2003; Hegde et al., 1997; Jiang et al., 1998; Speese etet al., 2000a; Tavalin et al., 2002). Interestingly, PP2B
and PKA are targeted to AMPA receptors by the synaptic al., 2003; Wilson et al., 2002; Zhao et al., 2003). Recently,
Figure 8. A Model for Ubiquitin-Mediated
Regulation of Surface AMPA Receptors
(A) PSD-95 indirectly interacts with AMPA re-
ceptors through stargazin. In addition, PSD-
95 also binds to Mdm2, a ubiquitin E3 ligase.
(B) In response to NMDA-induced calcium in-
flux, PP2B is activated, and PSD-95 is rapidly
ubiquitinated by associated Mdm2. PP2B
and PKA may be targeted to the synapse
through association with AKAP79/150.
(C) Following ubiquitination, PSD-95 is tar-
geted to the proteasome where it is degraded
(1). The loss of PSD-95 untethers AMPA recep-
tors from the PSD, allowing endocytosis (2).
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ubiquitination of C. elegans GLR-1 (a non-NMDA gluta- differences are likely to account, in part, for the differing
mate receptor subunit) was shown to regulate its abun- results. In addition, recent studies have shown that over-
dance at synaptic sites (Burbea et al., 2002). Our data expression of PSD-95 in hippocampal slices leads to an
are consistent with a conserved role for ubiquitination enhancement of LTD (Beique and Andrade, 2003; Stein
in regulating the number of synaptic AMPA receptors et al., 2003). Clearly, future studies are required to un-
in mammals—through degradation of their synaptic derstand the precise role PSD-95 plays in synaptic plas-
tethering protein PSD-95. ticity. It will be interesting to test the effects of ubiquit-
That two structurally distinct proteasome inhibitors ination-deficient mutants of PSD-95 on hippocampal
(MG132 and lactacystin) both block PSD-95 degrada- synaptic plasticity.
tion, and LTD strongly implicates a role for the protea- The data in this report suggest that ubiquitination and
some in these processes. However, it is also possible degradation of PSD-95 may be a molecular mechanism
that the lysosome may be involved in the regulation of underlying dynamic changes in AMPA receptor levels
PSD-95 stability and LTD. Although we did not detect at the synapse. Recent work showing that eye opening
ubiquitination of GluR2 in our experiments, our data causes the rapid redistribution of PSD-95 to dendrites
do not rule out the possibility that other mammalian in visual neurons (Yoshii et al., 2003) provides further
synaptic proteins, including AMPA receptor subunits support for a role for PSD-95 in activity-dependent syn-
themselves, also may be direct targets of the ubiquitin- aptic changes. Given that ubiquitination plays a role in
proteasome system. several forms of mammalian memory (Jiang et al., 1998;
Indeed, recent work shows that long-term changes in Lopez-Salon et al., 2001; Moss et al., 2002), future stud-
synaptic activity can alter the levels of a variety of PSD ies should focus on a role for ubiquitination and degra-
proteins in cultured rat neurons through the ubiquitin- dation of PSD-95 in memory formation and stability.
proteasome system (Ehlers, 2003). Of note is the fact
Experimental Proceduresthat Ehlers did not observe ubiquitination of PSD-95.
This is not surprising given that he screened for ubiquiti-
Expression Constructsnated proteins from unstimulated neurons (i.e., for pro-
The myc-tagged PSD-95 construct in GW1-CMV was a gift fromteins with a high basal level of ubiquitination). In fact,
Morgan Sheng, the HA-ubiquitin construct in pCMV was a gift of
in our experiments, we observed ubiquitination of PSD- Dirk Bohmann, and the myc-tagged p14ARF construct in pCDNA3
95 in cultured neurons only following NMDA stimulation was a gift of Yanping Zhang. Construction of the GST fusions pro-
(Figure 2A), consistent with Ehlers’ data. teins of PSD-95 domains has been described (Colledge et al., 2000).
PSD-95PEST mutant was generated by QuikChange Site-DirectedRecent reports have shown that the level of PSD-
mutagenesis (Stratagene); primers were designed to delete amino95 correlates with synaptic strength and maturation.
acids 10–25 of rat PSD-95.Overexpression of PSD-95 enhances AMPA receptor-
mediated synaptic transmission (Beique and Andrade, Antibodies
2003; El-Husseini et al., 2000; Schnell et al., 2002) and Antibodies used in immunoprecipitation experiments included
increases the number and size of dendritic spines (El- Mdm2 (Santa Cruz Biotechnology; rabbit polyclonal sc-7918); E6AP
(Affinity Bioreagents; rabbit polyclonal PA3-843); Parkin (Cell Signal-Husseini et al., 2000). In contrast, removal of PSD-95
ing Technologies; rabbit polyclonal #2132); Cbl (Santa Cruz; rabbitfrom the synaptic membrane downregulates AMPA
polyclonal sc-170); GluR1 (Upstate Biotechnology; rabbit peptidereceptor transmission (El-Husseini et al., 2002). Further-
06-306); AKAP150 (ICOS; rabbit polyclonal clone 4361J); and NR1more, PSD-95 mutant mice, which do not express syn-
(Upstate; rabbit polyclonal 06-311). For Western blots, the following
aptic PSD-95, also do not exhibit NMDA receptor- antibodies were used: ubiquitin (BD Pharmingen; mouse monoclonal
dependent LTD in the hippocampus (Migaud et al., 6C1.17; 1:2000); HA (Sigma; rabbit peptide H6903; 1:1000); PSD-95
1998). Our data demonstrate a direct role for PSD-95 (Upstate; mouse monoclonal K28/43; 1:10,000); myc (Santa Cruz;
mouse monoclonal 9E10; 1:2000); Mdm2 (mouse monoclonal 4B11ubiquitination in the endocytosis of AMPA receptors.
(Chen et al., 1993; 1:1000). In all cases, Western blots shown areOverexpression of PSD-95PEST—a mutant impaired
representative examples of experiments that were performed atin its ability to become ubiquitinated—dramatically
least three times.reduces NMDA-stimulated endocytosis of AMPA recep-
tors. In addition, we find that overexpression of wild- Brain Extract Preparation
type PSD-95 partially reduces AMPA receptor endocy- For immunoprecipitation of PSD-95-Mdm2 complexes, extracts of
tosis. We hypothesize that by interacting with AMPA rat forebrain crude synaptosomes were prepared by solubilization
in deoxycholic acid according to described procedures (Dunah etreceptors and other molecules in the PSD, PSD-95 sta-
al., 1998). Briefly, forebrain P2 fraction was extracted in 1% deoxy-bilizes surface AMPA receptors. In support of this
cholic acid and dialyzed overnight against 0.1% Triton X-100 andidea, previous studies have shown that association with
50 mM Tris (pH 7.4). Following centrifugation at 38,000 	 g for 30PSD-95 prevents internalization of Kv1.4 and the 
1-
min at 4C, 100 g of supernatant was incubated with 1–3 g of
adrenergic receptor (Hu et al., 2000; Jugloff et al., 2000), antibody and 30 l of prewashed protein A or G sepharose (50%
indicating that when bound to PSD-95, associated re- slurry) overnight at 4C. Following washing, bound proteins were
ceptors/channels may be prevented from undergoing eluted with SDS-sample buffer, separated by SDS-PAGE on a 4%–
15% gradient gel (Biorad), transferred to nitrocellulose membrane.endocytosis. By reducing ubiquitination, degradation,
Immunoreactive bands were visualized by enhanced chemilumines-and loss of synaptic PSD-95, the PEST mutant ampli-
cence (ECL; Amersham or Pierce) and captured on autoradiographyfies the effect of wild-type PSD-95.
film (Amersham Hyperfilm ECL or Kodak Biomax film).In contrast to our data, El-Husseini et al. (2002) found
that overexpression of wild-type PSD-95 increased glu- Transfection of Heterologous Cells
tamate-induced AMPA receptor internalization. We do HEK293 cells were transfected at 60%–80% confluency in 10 cm2
not fully understand the reasons for the apparent dis- plates using the calcium phosphate method. H1299 and MEFs were
transfected by Lipofectamine (Invitrogen). One to four g of eachcrepancy between this study and ours, but technical
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cDNA construct was transfected per dish. Cells were harvested and were defined as regions of staining intensity twice that of back-
ground on dendrite. Synaptic puncta were defined as regions oflysed 24 hr after transfection in 500 l RIPA buffer (1% Triton X-100,
0.1% SDS, 0.5% deoxycholic acid, 50 mM NaPO4, 150 mM NaCl, 2 staining overlapping synapsin 1 puncta. Puncta were delineated
manually in NIH image (average synaptic diameter 1.5 m), andmM EDTA and protease inhibitors). Cell extracts were analyzed
directly or were subjected to immunoprecipitation using 1–3 g average pixel intensity was measured.
antibody and 30 l of protein A or G Sepharose. Following overnight
incubation at 4C, the immunoprecipitates were washed and bound Transfection of Primary Neuronal Cultures and
proteins were analyzed by immunoblotting. Digital images, pro- Immunocytochemical Measurement of Endocytosis
duced by densitometric scans of autoradiographs on a ScanJet IIcx Primary hippocampal cultures were transfected using the calcium
(Hewlett Packard, Palo Alto, California) with DeskScan II software phosphate method (Xia et al., 1996) at 5 days in vitro (DIV). Endocyto-
(Hewlett Packard), were quantified using NIH Image 1.60 software. sis of AMPA receptors was examined at14 DIV using the antibody
feeding protocol (Ehlers, 2000; Lin et al., 2000). Surface GluR2 recep-
tors were labeled on living neurons (Chemicon MAB397; 1:200) atIn Vitro Ubiquitination Assay
The PSD-95 in vitro ubiquitination assay was performed as de- 37C for 30 min, prior to treatment with NMDA (20 M, 3 min).
Cultures were immediately rinsed and returned to the incubator forscribed previously (Honda et al., 1997) with some modifications.
The assay was carried out in a 20 l reaction mixture containing 50 an additional 27 min to allow endocytosis to occur. Cultures were
then fixed in 4% paraformaldehyde, 4% sucrose. Surface AMPAmM Tris-HCl (pH 8.0), 5 mM MgCl2, 0.5 mM DTT, 2 mM NaF, 3 M
okadaic acid, 100 ng GST-PSD-95, 100 ng MDM2, 200 ng UBA-1200 receptors were labeled with Alexa-568-conjugated (red) anti-mouse
secondary antibodies for 2 hr (1:250; data not shown). Cultures wereng UBC-5, 500 ng HA-ubiquitin, 5 mM ATP (Pharmacia Biotech), 1.5
mM ATPS (Fisher ICN). In control reactions, 100 ng His-p53 or then permeabilized for 1 min with 100% methanol and stained with
Alexa 488-conjugated (green) anti-mouse secondary antibody to100 ng GST were used in place of GST-PSD-95. The mixture was
incubated at 37C for 60 min and then analyzed by SDS-PAGE. label internalized AMPA receptors. To visualize PSD-95-transfected
neurons, cultures were labeled with anti-myc antibodies and Alexa-Ubiquitinated GST-PSD-95 was detected with anti-PSD-95 antibody
(Upstate Biotechnology; clone K28/43; 1:10,000). 633-conjugated (blue) anti-rabbit secondary antibodies.
Biochemical Measurements of Surface Receptor LevelsDissociated Hippocampal Neuron Culture
All rats were housed either in the Brown University Animal Care Methods for biotinylation experiments were previously described
(Snyder et al., 2001). Following treatment, 7- to 14-day-old high-Facility or Vollum Institute Animal Care Facility, and all procedures
were approved by institutional animal care and use committees. density cultured neurons were placed on ice to halt receptor traffick-
ing and washed twice with ice-cold artificial cerebrospinal fluidThe hippocampus was removed from P0-P2 rats, exposed to papain
(20 U/ml) at 37C for 60 min, and dissociated by trituration. Cells (ACSF; 124 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3,
0.8 mM MgCl2, 1.8 mM CaCl2, 10 mM dextrose, saturated with 95%were plated onto poly-lysine-coated (1 mg/ml) glass-bottomed
dishes. For immunocytochemistry, cells were plated at 75,000 cells/ O2 and 5% CO2.) Cultures were then incubated with ACSF containing
1 mg/ml Sulfo-NHS-LC-Biotin (Pierce Chemical Company) for 30ml (1.5 ml/dish); for biochemistry, cells were plated at 500,000 cells/
ml. Cultures were grown in media containing DMEM with 5% fetal min on ice. Cultures were rinsed in Tris buffered saline (TBS) to
quench the biotin reaction. Cultures were lysed in 300 l of RIPAbovine serum, 4 mM L-glutamine, B-27 nutrient supplement, penicil-
lin (5 U/ml), and streptomycin (5 g/ml). For immunoprecipitation of buffer. The homogenates were centrifuged at 14,000 	 g for 15 min
at 4C. The supernatant (200 l) was incubated with 100 l of 50%PSD-95 and GluR2, neurons were lysed in RIPA buffer (0.1% SDS,
0.5% deoxycholic acid, 1% Triton X-100, 50 mM NaPO4, 150 mM neutravidin agarose beads (Pierce Chemical Company) for 3 hr or
overnight at 4C. Neutravidin-bound proteins were washed threeNaCl, 2 mM EDTA, and protease inhibitors).
times with RIPA buffer and resuspended in 40 l of SDS sample
buffer and boiled. Quantitative Western blots were performed onImmunocytochemistry
biotinylated (surface) proteins using anti-GluR1 C-terminal (1:1000;Following experimental treatment, low-density neuronal cultures
Upstate Biotechnology); transferrin receptor antibodies (TfR; mono-were fixed in 4% paraformaldehyde with 4% sucrose for 5 min.
clonal clone H68.4; 1:1000 [0.5 g/ml]; Zymed Laboratories). Previ-Neurons were incubated in blocking buffer (20% fetal bovine serum
ous control experiments confirmed that the intracellular protein actinin PBS) for 1 hr and then exposed to antibodies against synapsin
was not biotinylated in this assay (n  3).1 (1:1000; Chemicon), Mdm2 (1:100; Santa Cruz), or PSD-95 (1:200;
MA1-045/046 Affinity Bioreagents) overnight at 4C in blocking
buffer. Cultures were then rinsed in blocking buffer containing 0.1% Electrophysiology
Long-Evans rats aged P14–P20 (Charles River) were deeply anesthe-Triton-X-100 for 20 min, exposed to the appropriate fluorescent
secondary antibodies (Jackson Immunoresearch) for 1 hr, and tized with an injection of D-beuthanasia. Following the disappear-
ance of corneal reflexes and a tail pinch response, the rat wasmounted in Vectashield. Omission of primary antibody was used as
a control for specificity of staining and showed only faint back- decapitated according to U.S. Department of Health and Human
Services and Brown University animal care guidelines. The brainground staining.
For surface label of AMPA receptors, neuronal cultures were was rapidly removed and placed into ice-cold dissection buffer
consisting of 212 mM sucrose, 10 mM glucose, 2.6 mM KCl, 1.23placed on ice to inhibit endocytosis, and surface receptors were
labeled with GluR2 antibodies directed against an extracellular epi- mM NaH2PO4, 26 mM NaHCO3, 9 mM MgCl2, and 1 mM CaCl2. Slices
of ventral hippocampus (350 m) were obtained using a vibrating-tope (Chemicon; MAB397; 1:100) for 30 min. Cultures were rinsed
twice for 15 min in PBS, fixed in 4% paraformaldehyde with 4% blade microtome (Leica VT1000S), and connections from CA3 and
subiculum were severed to prevent epileptiform activity. Slices weresucrose for 5 min, and blocked in PBS containing 10% normal goat
serum for 1 hr. For PSD-95 transfection experiments, cultures were transferred to a holding chamber containing ACSF that consisted
of 124 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1.23 mMpermeabilized with 0.25% Triton-X-100 and stained overnight at
4C with rabbit polyclonal antibodies directed against the myc tag NaH2PO4, 26 mM NaHCO3, and 10 mM dextrose. Slices were allowed
to recover at room temperature for a minimum of 1 hr prior to re-(Upstate Biotechnology; 1:200) to identify PSD-95-transfected cells.
Cultures were rinsed in blocking buffer two times 20 min at room cording.
For recordings, a slice was transferred to a submersion-type re-temperature and exposed to the appropriate fluorescent secondary
antibodies (Jackson Immunoresearch; 1:300) in blocking buffer cording chamber and perfused with room temperature (25C), oxy-
genated ACSF that also contained 50M picrotoxin to inhibit GABAAovernight at 4C. Cultures were rinsed three times 20 min and cover
slipped in Vectashield (Vector Laboratories). Cultures were exam- responses. Individual CA1 pyramidal neurons were visualized with
an inverted microscope (Nikon) outfitted with a 40	, 0.8 numericalined on a Olympus Fluoview 300 laser scanning confocal micro-
scope with experimenters blind to culture history. Images were col- aperture objective and IR-DIC optics. Whole-cell voltage-clamp re-
cordings were performed using patch pipettes made of thick-walledlected using Fluoview software and converted to NIH image files.
For quantification of PSD-95, GluR2, and Mdm2 staining, puncta glass (Sutter, 1.5 mm O.D., 0.86 mm I.D.) and filled with internal
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solution containing 107 mM D-gluconic acid, 107 mM CsOH, 5 mM Beique, J.C., and Andrade, R. (2003). PSD-95 regulates synaptic
transmission and plasticity in rat cerebral cortex. J. Physiol. 546,QX-314 chloride, 0.2 mM EGTA, 20 mM HEPES, 3.7 mM NaCl, 4
mM Mg-ATP, 0.3 mM Na-GTP, with pH adjusted to 7.2. Pipette 859–867.
resistances were 3–5 M. EPSCs were recorded with an Axopatch Burbea, M., Dreier, L., Dittman, J.S., Grunwald, M.E., and Kaplan,
200B amplifier (Axon Instruments), and data were acquired and J.M. (2002). Ubiquitin and AP180 regulate the abundance of GLR-1
analyzed using a system from DataWave Technologies (Boulder, glutamate receptors at postsynaptic elements in C. elegans. Neuron
CO) or pClamp 9 software and digidata 1332 digitizer (Union City, 35, 107–120.
CA). Experiments were included in the data set if the baseline period
Carroll, R.C., Beattie, E.C., Xia, H., Luscher, C., Altschuler, Y., Nicoll,
was stable, series resistance was stable (10%) for the recording
R.A., Malenka, R.C., and von Zastrow, M. (1999). Dynamin-depen-
duration, and monosynaptic EPSCs were evoked. Further, experi-
dent endocytosis of ionotropic glutamate receptors. Proc. Natl.
ments were excluded if Rs  35 M. There were no significant
Acad. Sci. USA 96, 14112–14117.
differences in the average series resistances for MG132 or DMSO
Chain, D.G., Schwartz, J.H., and Hegde, A.N. (1999). Ubiquitin-medi-control groups (20.2  3.8 and 16.0  1.2 M, respectively; p 
ated proteolysis in learning and memory. Mol. Neurobiol. 20, 125–142.0.3). EPSCs were elicited by delivering 100 s current pulses with a
Chen, J., Marechal, V., and Levine, A.J. (1993). Mapping of the p532-contact cluster electrode (FHC, 2	 25 m Pt/Ir) placed in stratum
and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107–4114.radiatum. Test stimuli were delivered at 0.33 Hz, and stimulation
intensity was titrated to elicit reliably a monosynaptic EPSC with Chen, L., Chetkovich, D.M., Petralia, R.S., Sweeney, N.T., Kawasaki,
few failures. The test potential for all recordings was 65 mV. LTD Y., Wenthold, R.J., Bredt, D.S., and Nicoll, R.A. (2000). Stargazin
was induced by pairing 1 Hz stimulation with membrane depolariza- regulates synaptic targeting of AMPA receptors by two distinct
tion to 40 mV for 200 pulses (Selig et al., 1995). For statistical mechanisms. Nature 408, 936–943.
comparisons of LTD, the EPSC peak amplitude was normalized to Colledge, M., Dean, R.A., Scott, G.K., Langeberg, L.K., Huganir, R.L.,
the average of a 15 min baseline period prior to the onset of the and Scott, J.D. (2000). Targeting of PKA to glutamate receptors
pairing protocol and then compared to a 5 min period beginning 25 through a MAGUK-AKAP complex. Neuron 27, 107–119.
min following the completion of the pairing protocol. The protea-
DiAntonio, A., Haghighi, A.P., Portman, S.L., Lee, J.D., Amaranto,some inhibitor MG132 (Calbiochem) was dissolved in DMSO, stored
A.M., and Goodman, C.S. (2001). Ubiquitination-dependent mecha-as a stock solution at 10 mM at 20C for no more than 1 month.
nisms regulate synaptic growth and function. Nature 412, 449–452.The MG132 stock solution was diluted 1:10,000 in internal solution
Dunah, A.W., Luo, J., Wang, Y.H., Yasuda, R.P., and Wolfe, B.B.to yield a final concentration of 1 M. Lactacystin (Calbiochem) was
(1998). Subunit composition of N-methyl-D-aspartate receptors inprepared as a stock solution at 10 mM and used at 10 M. MG132
the central nervous system that contain the NR2D subunit. Mol.and lactacystin experiments were interleaved with DMSO vehicle
Pharmacol. 53, 429–437.controls (0.01% by volume). QX-314 chloride was purchased from
Alomone Labs (Israel). All other reagents were from Sigma. Ehlers, M.D. (2000). Reinsertion or degradation of AMPA receptors
determined by activity-dependent endocytic sorting. Neuron 28,
Statistical Analysis 511–525.
For statistical analysis of time courses (Figures 1D, 5F, and 5G), Ehlers, M.D. (2003). Activity level controls postsynaptic composition
one-way analysis of variance (ANOVA) with Bonferoni post hoc com- and signaling via the ubiquitin-proteasome system. Nat. Neurosci.
parisons were made. For analysis of LTD time courses (Figure 7), 10, 10.
ANOVA followed by Fisher’s PLSD post hoc tests were used with
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., and
significance placed at p 0.05. In all other cases, statistical compar-
Bredt, D.S. (2000). PSD-95 involvement in maturation of excitatory
isons were made using unpaired t tests with significance placed at
synapses. Science 290, 1364–1368.
p  0.05 and data are expressed as mean  SEM. Statistics were
El-Husseini, A.E., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q.,performed using StatView or Prism 3.0 software.
Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R.A.,
and Bredt, D.S. (2002). Synaptic strength regulated by palmitateAcknowledgments
cycling on PSD-95. Cell 108, 849–863.
Gardiol, D., Kuhne, C., Glaunsinger, B., Lee, S.S., Javier, R., andWe thank Dr. Mathew Thayer (OHSU) for Mdm2 constructs, Dr.
Banks, L. (1999). Oncogenic human papillomavirus E6 proteins tar-Dirk Bohmann (EMBL, Heidelberg, Germany) for the HA-ubiquitin
get the discs large tumour suppressor for proteasome-mediatedconstruct, Dr. Morgan Sheng (MIT) for the PSD-95 construct, and
degradation. Oncogene 18, 5487–5496.Dr. Yanping Zhang for the p14ARF construct. We thank Mushui Dai
for generation and purification of Mdm2. We thank Robert Mouton, Glaunsinger, B.A., Lee, S.S., Thomas, M., Banks, L., and Javier,
Nicole Bonnett, and Ian Townley for providing cell culture assis- R. (2000). Interactions of the PDZ-protein MAGI-1 with adenovirus
tance. We are grateful to members of the Scott and Bear labs for their E4–ORF1 and high- risk papillomavirus E6 oncoproteins. Oncogene
support and advice during this work. In particular, we appreciate the 19, 5270–5280.
advice of Dr. Jennifer Michel. This work was supported by NIH Hegde, A.N., and DiAntonio, A. (2002). Ubiquitin and the synapse.
grants GM48231 to J.D.S. and NS39321 to M.F.B. and from a CIHR Nat. Rev. Neurosci. 3, 854–861.
grant to M.C.
Hegde, A.N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain,
D.G., Martin, K.C., Kandel, E.R., and Schwartz, J.H. (1997). UbiquitinReceived: February 26, 2003
C-terminal hydrolase is an immediate-early gene essential for long-Revised: September 16, 2003
term facilitation in Aplysia. Cell 89, 115–126.Accepted: October 15, 2003
Heynen, A.J., Quinlan, E.M., Bae, D.C., and Bear, M.F. (2000). Bidi-Published: October 29, 2003
rectional, activity-dependent regulation of glutamate receptors in
the adult hippocampus in vivo. Neuron 28, 527–536.References
Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2
Banke, T.G., Bowie, D., Lee, H., Huganir, R.L., Schousboe, A., and is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420,
Traynelis, S.F. (2000). Control of GluR1 AMPA receptor function by 25–27.
cAMP-dependent protein kinase. J. Neurosci. 20, 89–102. Hu, L.A., Tang, Y., Miller, W.E., Cong, M., Lau, A.G., Lefkowitz, R.J.,
Bear, M.F., and Malenka, R.C. (1994). Synaptic plasticity: LTP and and Hall, R.A. (2000). beta 1-adrenergic receptor association with
LTD. Curr. Opin. Neurobiol. 4, 389–399. PSD-95. Inhibition of receptor internalization and facilitation of beta
1-adrenergic receptor interaction with N-methyl-D-aspartate recep-Beattie, E.C., Carroll, R.C., Yu, X., Morishita, W., Yasuda, H., von
tors. J. Biol. Chem. 275, 38659–38666.Zastrow, M., and Malenka, R.C. (2000). Regulation of AMPA receptor
endocytosis by a signaling mechanism shared with LTD. Nat. Neu- Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L.,
Eichele, G., Sweatt, J.D., and Beaudet, A.L. (1998). Mutation of therosci. 3, 1291–1300.
Ubiquitin Regulation of Glutamatergic Synapses
607
Angelman ubiquitin ligase in mice causes increased cytoplasmic kinase–AKAP79–phosphatase scaffold complexes at the plasma
membrane in living cells using FRET microscopy. J. Cell Biol.p53 and deficits of contextual learning and long-term potentiation.
Neuron 21, 799–811. 160, 101–112.
Pickart, C.M. (2000). Ubiquitin in chains. Trends Biochem. Sci. 25,Joazeiro, C.A., and Hunter, T. (2000). Biochemistry. Ubiquitination–
544–548.more than two to tango. Science 289, 2061–2062.
Rechsteiner, M., and Rogers, S.W. (1996). PEST sequences andJugloff, D.G., Khanna, R., Schlichter, L.C., and Jones, O.T. (2000).
regulation by proteolysis. Trends Biochem. Sci. 21, 267–271.Internalization of the Kv1.4 potassium channel is suppressed by
clustering interactions with PSD-95. J. Biol. Chem. 275, 1357–1364. Rosenmund, C., Carr, D.W., Bergeson, S.E., Nilaver, G., Scott, J.D.,
and Westbrook, G.L. (1994). Anchoring of protein kinase A is requiredKameyama, K., Lee, H.K., Bear, M.F., and Huganir, R.L. (1998).
for modulation of AMPA/kainate receptors on hippocampal neurons.Involvement of a postsynaptic protein kinase A substrate in the
Nature 368, 853–856.expression of homosynaptic long-term depression. Neuron 21,
1163–1175. Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S.,
and Nicoll, R.A. (2002). Direct interactions between PSD-95 andLee, H.K., Kameyama, K., Huganir, R.L., and Bear, M.F. (1998).
stargazin control synaptic AMPA receptor number. Proc. Natl. Acad.NMDA induces long-term synaptic depression and dephosphoryla-
Sci. USA 99, 13902–13907.tion of the GluR1 subunit of AMPA receptors in hippocampus. Neu-
ron 21, 1151–1162. Selig, D.K., Hjelmstad, G.O., Herron, C., Nicoll, R.A., and Malenka,
R.C. (1995). Independent mechanisms for long-term depression ofLee, H.K., Barbarosie, M., Kameyama, K., Bear, M.F., and Huganir,
AMPA and NMDA responses. Neuron 15, 417–426.R.L. (2000a). Regulation of distinct AMPA receptor phosphorylation
sites during bidirectional synaptic plasticity. Nature 405, 955–959. Sheng, M. (2001). Molecular organization of the postsynaptic spe-
cialization. Proc. Natl. Acad. Sci. USA 98, 7058–7061.Lee, S.S., Glaunsinger, B., Mantovani, F., Banks, L., and Javier, R.T.
(2000b). Multi-PDZ domain protein MUPP1 is a cellular target for Sherr, C.J., and Weber, J.D. (2000). The ARF/p53 pathway. Curr.
both adenovirus E4–ORF1 and high-risk papillomavirus type 18 E6 Opin. Genet. Dev. 10, 94–99.
oncoproteins. J. Virol. 74, 9680–9693. Shi, S., Hayashi, Y., Esteban, J.A., and Malinow, R. (2001). Subunit-
Liao, D., Zhang, X., O’Brien, R., Ehlers, R.O., and Huganir, R.L. (1999). specific rules governing AMPA receptor trafficking to synapses in
Regulation of morphological postsynaptic silent synapses in devel- hippocampal pyramidal neurons. Cell 105, 331–343.
oping hippocampal neurons. Nat. Neurosci. 2, 37–43. Snyder, E.M., Philpot, B.D., Huber, K.M., Dong, X., Fallon, J.R., and
Lin, J.W., Ju, W., Foster, K., Lee, S.H., Ahmadian, G., Wyszynski, Bear, M.F. (2001). Internalization of ionotropic glutamate receptors
M., Wang, Y.T., and Sheng, M. (2000). Distinct molecular mecha- in response to mGluR activation. Nat. Neurosci. 4, 1079–1085.
nisms and divergent endocytotic pathways of AMPA receptor inter- Speese, S.D., Trotta, N., Rodesch, C.K., Aravamudan, B., and Broa-
nalization. Nat. Neurosci. 3, 1282–1290. die, K. (2003). The ubiquitin proteasome system acutely regulates
Liu, J., Farmer, J.D., Jr., Lane, W.S., Friedman, J., Weissman, I., and presynaptic protein turnover and synaptic efficacy. Curr. Biol. 13,
Schreiber, S.L. (1991). Calcineurin is a common target of cyclophilin- 899–910.
cyclosporin A and FKBP-FK506 complexes. Cell 66, 807–815. Stein, V., House, D.R.C., Bredt, D.S., and Nicoll, R.A. (2003). Postsyn-
Lopez-Salon, M., Alonso, M., Vianna, M.R., Viola, H., Mello e Souza, aptic Density-95 mimics and occludes hippocampal long-term po-
T., Izquierdo, I., Pasquini, J.M., and Medina, J.H. (2001). The ubiqui- tentiation and enhances long-term depression. J. Neurosci. 23,
tin-proteasome cascade is required for mammalian long-term mem- 5503–5506.
ory formation. Eur. J. Neurosci. 14, 1820–1826. Tavalin, S.J., Colledge, M., Hell, J.W., Langeberg, L.K., Huganir,
Lu, W., Man, H., Ju, W., Trimble, W.S., MacDonald, J.F., and Wang, R.L., and Scott, J.D. (2002). Regulation of GluR1 by the A-kinase
Y.T. (2001). Activation of synaptic NMDA receptors induces mem- anchoring protein 79 (AKAP79) signaling complex shares properties
brane insertion of new AMPA receptors and LTP in cultured hippo- with long-term depression. J. Neurosci. 22, 3044–3051.
campal neurons. Neuron 29, 243–254. Weissman, A.M. (2001). Themes and variations on ubiquitylation.
Lu¨scher, C., Xia, H., Beattie, E.C., Carroll, R.C., von Zastrow, M., Nat. Rev. Mol. Cell Biol. 2, 169–178.
Malenka, R.C., and Nicoll, R.A. (1999). Role of AMPA receptor cycling Wilson, S.M., Bhattacharyya, B., Rachel, R.A., Coppola, V., Tessaro-
in synaptic transmission and plasticity. Neuron 24, 649–658. llo, L., Householder, D.B., Fletcher, C.F., Miller, R.J., Copeland, N.G.,
Malinow, R., and Malenka, R.C. (2002). AMPA receptor trafficking and Jenkins, N.A. (2002). Synaptic defects in ataxia mice result from
and synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126. a mutation in Usp14, encoding a ubiquitin-specific protease. Nat.
Genet. 32, 420–425.Man, H.-Y., Lin, J.W., Ju, W.H., Ahmadian, G., Liu, L., Becker, L.E.,
Sheng, M., and Wang, Y.T. (2000). Regulation of AMPA receptor- Xia, Z., Dudek, H., Miranti, C.K., and Greenberg, M.E. (1996). Calcium
mediated synaptic transmission by clathrin-dependent receptor in- influx via the NMDA receptor induces immediate early gene tran-
ternalization. Neuron 25, 649–662. scription by a MAP kinase/ERK-dependent mechanism. J. Neurosci.
16, 5425–5436.Migaud, M., Charlesworth, P., Dempster, M., Webster, L.C., Watabe,
A.M., Makhinson, M., He, Y., Ramsay, M.F., Morris, R.G., Morrison, Yoshii, A., Sheng, M.H., and Constantine-Paton, M. (2003). Eye
J.H., et al. (1998). Enhanced long-term potentiation and impaired opening induces a rapid dendritic localization of PSD-95 in central
learning in mice with mutant postsynaptic density-95 protein. Nature visual neurons. Proc. Natl. Acad. Sci. USA 100, 1334–1339.
396, 433–439. Zeng, H., Chattarji, S., Barbarosie, M., Rondi-Reig, L., Philpot, B.D.,
Montes de Oca Luna, R., Wagner, D.S., and Lozano, G. (1995). Miyakawa, T., Bear, M.F., and Tonegawa, S. (2001). Forebrain-spe-
Rescue of early embryonic lethality in mdm2-deficient mice by dele- cific calcineurin knockout selectively impairs bidirectional synaptic
tion of p53. Nature 378, 203–206. plasticity and working/episodic-like memory. Cell 107, 617–629.
Moss, A., Blackburn-Munro, G., Garry, E.M., Blakemore, J.A., Dickin- Zhao, Y., Hegde, A.N., and Martin, K.C. (2003). The ubiquitin protea-
son, T., Rosie, R., Mitchell, R., and Fleetwood-Walker, S.M. (2002). some system functions as an inhibitory constraint on synaptic
A role of the ubiquitin-proteasome system in neuropathic pain. J. strengthening. Curr. Biol. 13, 887–898.
Neurosci. 22, 1363–1372.
Mulkey, R.M., Endo, S., Shenolikar, S., and Malenka, R.C. (1994).
Involvement of a calcineurin/inhibitor-1 phosphatase cascade in
hippocampal long-term depression. Nature 369, 486–488.
Murphey, R.K., and Godenschwege, T.A. (2002). New roles for ubi-
quitin in the assembly and function of neuronal circuits. Neuron
36, 5–8.
Oliveria, S.F., Gomez, L.L., and Dell’Acqua, M.L. (2003). Imaging
